Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
This is a summary aggregated from CNBC. Read the complete article on the original site:
Read full article at CNBC
